348 related articles for article (PubMed ID: 29859985)
41. Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity.
Yan F; Zhang GH; Feng M; Zhang W; Zhang JN; Dong WQ; Zhang C; Zhang Y; Chen L; Zhang MX
Mol Med; 2015 Feb; 21(1):15-25. PubMed ID: 25715248
[TBL] [Abstract][Full Text] [Related]
42. miR-200b Mediates Endothelial-to-Mesenchymal Transition in Diabetic Cardiomyopathy.
Feng B; Cao Y; Chen S; Chu X; Chu Y; Chakrabarti S
Diabetes; 2016 Mar; 65(3):768-79. PubMed ID: 26718496
[TBL] [Abstract][Full Text] [Related]
43. Melatonin Attenuates Endothelial-to-Mesenchymal Transition of Glomerular Endothelial Cells via Regulating miR-497/ROCK in Diabetic Nephropathy.
Liu F; Zhang S; Xu R; Gao S; Yin J
Kidney Blood Press Res; 2018; 43(5):1425-1436. PubMed ID: 30212830
[TBL] [Abstract][Full Text] [Related]
44. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
45. Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT.
Ghosh AK; Nagpal V; Covington JW; Michaels MA; Vaughan DE
Cell Signal; 2012 May; 24(5):1031-6. PubMed ID: 22245495
[TBL] [Abstract][Full Text] [Related]
46. Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression.
Guo Y; Li P; Bledsoe G; Yang ZR; Chao L; Chao J
Exp Cell Res; 2015 Sep; 337(1):103-10. PubMed ID: 26156753
[TBL] [Abstract][Full Text] [Related]
47. CXCR7 attenuates the TGF-β-induced endothelial-to-mesenchymal transition and pulmonary fibrosis.
Guan S; Zhou J
Mol Biosyst; 2017 Sep; 13(10):2116-2124. PubMed ID: 28820530
[TBL] [Abstract][Full Text] [Related]
48. MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway.
Geng H; Guan J
Biochem Biophys Res Commun; 2017 Sep; 491(2):329-336. PubMed ID: 28733035
[TBL] [Abstract][Full Text] [Related]
49. TGF-β1-miR-200a-PTEN induces epithelial-mesenchymal transition and fibrosis of pancreatic stellate cells.
Xu M; Wang G; Zhou H; Cai J; Li P; Zhou M; Lu Y; Jiang X; Huang H; Zhang Y; Gong A
Mol Cell Biochem; 2017 Jul; 431(1-2):161-168. PubMed ID: 28281184
[TBL] [Abstract][Full Text] [Related]
50. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
51. Downregulation of acylglycerol kinase suppresses high-glucose-induced endothelial-mesenchymal transition in human retinal microvascular endothelial cells through regulating the LPAR1/TGF-β/Notch signaling pathway.
Wang H; Feng Z; Han X; Xing Y; Zhang X
Can J Physiol Pharmacol; 2022 Feb; 100(2):142-150. PubMed ID: 34559978
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis.
Song S; Liu L; Yu Y; Zhang R; Li Y; Cao W; Xiao Y; Fang G; Li Z; Wang X; Wang Q; Zhao X; Chen L; Wang Y; Wang Q
J Mol Cell Cardiol; 2019 Feb; 127():83-96. PubMed ID: 30529267
[TBL] [Abstract][Full Text] [Related]
53. Transcriptional induction of TGF-β1 and endothelial-to-mesenchymal transition cell markers in human umbilical vein endothelial cells by Ebola virus infection.
Ro YT; Patterson JL
Genes Genomics; 2022 Dec; 44(12):1499-1507. PubMed ID: 36331778
[TBL] [Abstract][Full Text] [Related]
54. Losartan Attenuates Myocardial Endothelial-To-Mesenchymal Transition in Spontaneous Hypertensive Rats via Inhibiting TGF-β/Smad Signaling.
Wu M; Peng Z; Zu C; Ma J; Lu S; Zhong J; Zhang S
PLoS One; 2016; 11(5):e0155730. PubMed ID: 27176484
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA 9 Is a Regulator of Endothelial to Mesenchymal Transition in Diabetic Retinopathy.
Wang E; Feng B; Chakrabarti S
Invest Ophthalmol Vis Sci; 2023 Jun; 64(7):13. PubMed ID: 37279396
[TBL] [Abstract][Full Text] [Related]
56. Anti-Fibrosis Effect of Relaxin and Spironolactone Combined on Isoprenaline-Induced Myocardial Fibrosis in Rats via Inhibition of Endothelial-Mesenchymal Transition.
Cai J; Chen X; Chen X; Chen L; Zheng G; Zhou H; Zhou X
Cell Physiol Biochem; 2017; 41(3):1167-1178. PubMed ID: 28245473
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of miR-122 reduced atherosclerotic lesion formation by regulating NPAS3-mediated endothelial to mesenchymal transition.
Wu X; Du X; Yang Y; Liu X; Liu X; Zhang N; Li Y; Jiang X; Jiang Y; Yang Z
Life Sci; 2021 Jan; 265():118816. PubMed ID: 33278397
[TBL] [Abstract][Full Text] [Related]
58. 27-Hydroxycholesterol-induced EndMT acts
Jiao K; Zhen J; Wu M; Teng M; Yang K; Zhou Q; Hu C; Zhou M; Li Y; Li Z
Cancer Biol Med; 2020 Feb; 17(1):88-100. PubMed ID: 32296578
[No Abstract] [Full Text] [Related]
59. MicroRNA-148b Targets the TGF-β Pathway to Regulate Angiogenesis and Endothelial-to-Mesenchymal Transition during Skin Wound Healing.
Miscianinov V; Martello A; Rose L; Parish E; Cathcart B; Mitić T; Gray GA; Meloni M; Al Haj Zen A; Caporali A
Mol Ther; 2018 Aug; 26(8):1996-2007. PubMed ID: 29843955
[TBL] [Abstract][Full Text] [Related]
60. Aspirin-Triggered Resolvin D1 Inhibits TGF-β1-Induced EndMT through Increasing the Expression of Smad7 and Is Closely Related to Oxidative Stress.
Shu Y; Liu Y; Li X; Cao L; Yuan X; Li W; Cao Q
Biomol Ther (Seoul); 2016 Mar; 24(2):132-9. PubMed ID: 26869523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
